Pistis, Kristin Danielson
Westerberg, Per-Anton
Qureshi, Abdul Rashid
Beshara, Soheir
Sterner, Gunnar
Bárány, Peter
Linde, Torbjörn
Funding for this research was provided by:
Karolinska Institute
Article History
Received: 11 January 2022
Accepted: 21 November 2022
First Online: 25 January 2023
Declarations
:
: The study complied with the Declaration of Helsinki. The regional Ethical Review board in Uppsala (Ref 2011/313), in addition to the Swedish Medical Products Agency, approved the protocol of the study. Informed consent was obtained from all individual participants included in the study.
: N/A
: Kristin Danielson Pistis is employed by Renapharma AB. PW, ARQ, SB, GS, PB and TL have no conflict of interest.